Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
BG12 will be the oral MS drug of choice. Gilenya will fail
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 3931978"]Wow - you cannot do math. Patient rise is not so great, but the rate of PML cases is increasing. Nine more cases this month, seven last month, ten the month before that. There was a steady average of five cases per month prior. What you are seeing is a number of patients in the 2-3 year range emerging and that rate is close to 1 in 500. </p><p><br /></p><p>Not many patients are new to Tysabri and quite a few are dropping the drug. </p><p><br /></p><p>Read before you speak.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 3931978"]Wow - you cannot do math. Patient rise is not so great, but the rate of PML cases is increasing. Nine more cases this month, seven last month, ten the month before that. There was a steady average of five cases per month prior. What you are seeing is a number of patients in the 2-3 year range emerging and that rate is close to 1 in 500. Not many patients are new to Tysabri and quite a few are dropping the drug. Read before you speak.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
BG12 will be the oral MS drug of choice. Gilenya will fail
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
BG12 will be the oral MS drug of choice. Gilenya will fail
>